Recent Phase I vaccine trials
Below is a list of phase I trials performed since 2011, for trials conducted before, contact: cev@uantwerpen.be
Proof Of Concept Study: Immunogenicity and Safety of Hepatitis B Injection in the Dermis in Healthy Volunteers Using an Intradermal Injection Device (VAX-ID)
- ClinicalTrials.gov Identifier: NCT02186977
- Phase: I
- Population age: adults (18 to 35y)
- Gender: male,female
- Starting year @CEV: 2016
A Study to Evaluate the Safety, Reactogenicity and Immunogenicity of the Investigational GSK Biologicals' GSK3277511A Vaccine in Adults.
- EudraCT number: 2015-000378-36
- ClinicalTrials.gov Identifier: NCT02547974
- Sponsor protocol number: 201281
- Centre code: NTHI MCAT-001
- Phase: I
- Population age: adults (18 to 40y & 50-70y with smoking history)
- Gender: male,female
- Starting year @CEV: 2015
Safety, Tolerability, and Immunogenicity Study of a Cell-based Virosomal Influenza Vaccine in Healthy Adults
- EudraCT number:2014-000573-39
- ClinicalTrials.gov Identifier: NCT02148328
- Sponsor protocol number: Flucell
- Centre code:
- Phase: I
- Population age: adults (18 to 49y)
- Gender: male,female
- Starting year @CEV: 2014
Clinical Study for Safety and Immunogenicity Study of Influenza Vaccine
- EudraCT number: 2012-001693-28
- ClinicalTrials.gov Identifier: NCT01617239
- Sponsor protocol number: INF-V-A017
- Centre code:
- Phase: I
- Population age: adults (18 to 50y)
- Gender: male,female
- Starting year @CEV: 2012
A Study to Evaluate the Safety, Reactogenicity and Immunogenicity of GSK Biologicals' Non-typeable Haemophilus Influenzae (NTHi) Investigational Vaccine (GSK2838497A) in Current and Former Smokers
- EudraCT number: 2012-001238-32
- ClinicalTrials.gov Identifier: NCT01678677
- Sponsor protocol number: NTHI-003
- Centre code:
- Phase: I
- Population age: adults (50 to 70y, smokers)
- Gender: male,female
- Starting year @CEV: 2012